MedTrace Logo

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome

NCT06951386 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-05-04

No results posted yet for this study

Summary

During this study, the effect of short-chain fatty acids on blood lipaedemia, glycemia, anthropometrics, blood pressure and energy expenditure will be investigated.

Conditions

  • Energy Expenditure
  • Metabolic Syndrome
  • Anthropometry
  • Body Composition
  • Glycemia
  • Lipaemia
  • Metabolomics
  • Blood Pressure

Interventions

DIETARY_SUPPLEMENT

with short-chain fatty acids enriched drink

Oat-based drink enriched with 15 g/L short-chain fatty acids

DIETARY_SUPPLEMENT

unenriched oat drink

Oat-based drink

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Kristin Verbeke, Prof. · KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06951386 on ClinicalTrials.gov